Complement C5 inhibition in patients with COVID-19 - a promising target?
Haematologica
; 105(12): 2847-2850, 2020 12 01.
Article
in English
| MEDLINE | ID: covidwho-676578
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Complement C5
/
Complement Inactivating Agents
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Haematologica
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS